These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21210267)

  • 21. Glyburide ameliorates motor coordination and glucose homeostasis in a child with diabetes associated with the KCNJ11/S225T, del226-232 mutation.
    Battaglia D; Lin YW; Brogna C; Crinò A; Grasso V; Mozzi AF; Russo L; Spera S; Colombo C; Ricci S; Nichols CG; Mercuri E; Barbetti F
    Pediatr Diabetes; 2012 Dec; 13(8):656-60. PubMed ID: 22694282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Personalized precision medicine in extreme preterm infants with transient neonatal diabetes mellitus.
    Kylat RI; Senguttuvan R; Bader MY
    J Pediatr Endocrinol Metab; 2017 May; 30(5):593-596. PubMed ID: 28350539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First case of neonatal diabetes with KCNJ11 Q52R mutation successfully switched from insulin to sulphonylurea treatment.
    Ioacara S; Flanagan S; Fröhlich-Reiterer E; Goland R; Fica S
    J Diabetes Investig; 2017 Sep; 8(5):716-719. PubMed ID: 28083968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unsuccessful switch from insulin to sulfonylurea therapy in permanent neonatal diabetes mellitus due to an R201H mutation in the KCNJ11 gene: a case report.
    Heo JW; Kim SW; Cho EH
    Diabetes Res Clin Pract; 2013 Apr; 100(1):e1-2. PubMed ID: 23434183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful transition from insulin to sulfonylurea therapy in a patient with monogenic neonatal diabetes owing to a KCNJ11 F333L [corrected] mutation.
    Philla KQ; Bauer AJ; Vogt KS; Greeley SA
    Diabetes Care; 2013 Dec; 36(12):e201. PubMed ID: 24265373
    [No Abstract]   [Full Text] [Related]  

  • 26. DEND syndrome due to V59A mutation in KCNJ11 gene: unresponsive to sulfonylureas.
    Itoh S; Matsuoka H; Yasuda Y; Miyake N; Suzuki K; Yorifuji T; Sugihara S
    J Pediatr Endocrinol Metab; 2013; 26(1-2):143-6. PubMed ID: 23382304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain.
    Shimomura K; Hörster F; de Wet H; Flanagan SE; Ellard S; Hattersley AT; Wolf NI; Ashcroft F; Ebinger F
    Neurology; 2007 Sep; 69(13):1342-9. PubMed ID: 17652641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Low doses of sulphonyluria as a successful replacement for insulin therapy in a patient with neonatal diabetes due to a mutation of KCNJ11 gene encoding Kir6.2].
    Ille J; Putarek NR; Radica A; Hattersley A; Ellard S; Dumić M
    Lijec Vjesn; 2010; 132(3-4):90-3. PubMed ID: 20540435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful sulfonylurea treatment of an insulin-naïve neonate with diabetes mellitus due to a KCNJ11 mutation.
    Wambach JA; Marshall BA; Koster JC; White NH; Nichols CG
    Pediatr Diabetes; 2010 Jun; 11(4):286-8. PubMed ID: 19656320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Personalized medicine switching from insulin to sulfonylurea in permanent neonatal diabetes mellitus dictated by a novel activating ABCC8 mutation.
    Mak CM; Lee CY; Lam CW; Siu WK; Hung VC; Chan AY
    Diagn Mol Pathol; 2012 Mar; 21(1):56-9. PubMed ID: 22306677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetes.
    Iafusco D; Bizzarri C; Cadario F; Pesavento R; Tonini G; Tumini S; Cauvin V; Colombo C; Bonfanti R; Barbetti F
    Diabetologia; 2011 Oct; 54(10):2736-8. PubMed ID: 21822789
    [No Abstract]   [Full Text] [Related]  

  • 32. Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide.
    Bremer AA; Ranadive S; Lustig RH
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):236-9. PubMed ID: 18221420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Permanent neonatal diabetes by a new mutation in KCNJ11: unsuccessful switch to sulfonylurea.
    Lau E; Correia C; Freitas P; Nogueira C; Costa M; Saavedra A; Costa C; Carvalho D; Fontoura M
    Arch Endocrinol Metab; 2015 Dec; 59(6):559-61. PubMed ID: 26331221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transient neonatal diabetes mellitus is associated with a recurrent (R201H) KCNJ11 (KIR6.2) mutation.
    Colombo C; Delvecchio M; Zecchino C; Faienza MF; Cavallo L; Barbetti F;
    Diabetologia; 2005 Nov; 48(11):2439-41. PubMed ID: 16205880
    [No Abstract]   [Full Text] [Related]  

  • 35. KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features.
    Gloyn AL; Diatloff-Zito C; Edghill EL; Bellanné-Chantelot C; Nivot S; Coutant R; Ellard S; Hattersley AT; Robert JJ
    Eur J Hum Genet; 2006 Jul; 14(7):824-30. PubMed ID: 16670688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A successful transition to sulfonylurea treatment in male infant with neonatal diabetes caused by the novel abcc8 gene mutation and three years follow-up.
    Katanic D; Vorgučin I; Hattersley A; Ellard S; Houghton JAL; Obreht D; Knežević Pogančev M; Vlaški J; Pavkov D
    Diabetes Res Clin Pract; 2017 Jul; 129():59-61. PubMed ID: 28511139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neonatal diabetes mellitus due to a new KCNJ11 mutation - 10 years of the patient`s follow-up.
    Ješić MD; Stock H; Zdravković V; Kovačević S; Savić M; Ješić MM
    Turk J Pediatr; 2021; 63(3):490-494. PubMed ID: 34254494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term efficacy of glibenclamide and sitagliptin therapy in adult patients with KCNJ11 permanent diabetes.
    Sastre J; Luque A; del Val F; Aragonés A; López J
    Diabetes Care; 2014; 37(3):e55-6. PubMed ID: 24558086
    [No Abstract]   [Full Text] [Related]  

  • 39. Permanent neonatal diabetes mellitus - a case report of a rare cause of diabetes mellitus in East Africa.
    Nyangabyaki-Twesigye C; Muhame MR; Bahendeka S
    Afr Health Sci; 2015 Dec; 15(4):1339-41. PubMed ID: 26958039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and Molecular Characterization of Children with Neonatal Diabetes Mellitus at a Tertiary Care Center in Northern India.
    Jain V; Satapathy A; Yadav J; Sharma R; Radha V; Mohan V; De Franco E; Ellard S
    Indian Pediatr; 2017 Jun; 54(6):467-471. PubMed ID: 28667717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.